Overview

Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia

Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The role of ultralong insulin in the control of the blood glucose level in diabetic patients is well known, the current study will discuss the role of ultralong insulin in controlling of hyperglycaemia in critical illness defined as failure or impending failure of an organ
Phase:
N/A
Details
Lead Sponsor:
Ain Shams University
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc